Deep learning and multi-omics drive smarter, personalized oncology treatments

 

New developments in artificial intelligence are enabling the integration of multi-omics data to refine precision oncology decision-making. By utilizing deep learning algorithms, researchers can now synthesize vast datasets—combining genomics, transcriptomics, and proteomics—to identify complex biomarker patterns that single-omics approaches often miss. This holistic analysis allows for more accurate predictions of how individual patients will respond to specific cancer therapies.
The integration of these diverse data layers represents a shift towards truly personalized medicine. Rather than relying on a single genetic mutation to guide treatment, clinicians can leverage these AI-driven insights to understand the tumor's biological landscape comprehensively.

This approach holds the promise of reducing trial-and-error prescribing and improving clinical outcomes by matching patients with the most effective therapeutic regimens from the outset.


Read the original article at: https://www.genengnews.com/topics/artificial-intelligence/deep-learning-integrates-multi-omics-for-precision-oncology-decision-making/



Follow us on Instagram, Twitter, and Facebook to stay up to date with what's new in healthcare all around the world.

Comments

Post a Comment

Popular posts from this blog

Guesswork gone. A new scoring system (ST-RADS) predicts soft-tissue tumor malignancy with 99.2% accuracy.

Image
 Radiologists may soon have a powerful new standard for evaluating soft-tissue tumors. A study detailed in Radiology Business introduces "ST-RADS" (Soft-Tissue Tumor Reporting and Data System), a structured MRI scoring framework designed to replace the often vague descriptive reports currently in use. In a validation study involving roughly 200 patients, the ST-RADS system demonstrated exceptional precision, achieving a 99.2% accuracy rate in predicting malignancy—significantly outperforming the 92.8% accuracy of standard radiological reports. Crucially, the system was perfect (100% accuracy) in identifying benign tumors, a capability that could drastically reduce unnecessary biopsies and patient anxiety. By standardizing how these complex images are interpreted, ST-RADS offers a clear, objective roadmap for clinicians, ensuring that aggressive cancers are flagged immediately while harmless lumps are safely monitored without invasive intervention. Read the original artic...
Read more

The system is too slow. New data reveals that missed "waiting time" targets are hiding the true, deadly cost of cancer care.

Image
 A critical new analysis argues that current targets for cancer treatment waiting times are failing patients and obscuring the true extent of delays. The report highlights that arbitrary benchmarks such as the 62 day target from referral to treatment are frequently missed and do not account for the increasing complexity of modern cancer care. Patients requiring multiple diagnostic tests often face much longer waits that are not accurately reflected in official data. These delays are not merely administrative nuisances they significantly increase the risk of mortality.  The authors contend that simply setting stricter targets is ineffective without addressing the underlying lack of resources. Instead they call for a national learning system driven by data and collaboration to identify bottlenecks in real time and prioritize patients based on clinical urgency rather than outdated metrics. Read the original article at: http://www.bmj.com/content/392/bmj.s14.short?rss=1 Follow ...
Read more

Patients now understand the risk numbers perfectly, yet anxiety still drives them to choose preventive surgery

Image
 A new study examining genetic counseling reveals a complex gap between understanding statistics and making medical decisions. Researchers tested a visual aid designed to help breast cancer patients understand their specific risk of developing cancer in the opposite breast. While the tool successfully improved the patients accuracy in estimating their numerical risk it surprisingly had little impact on their actual choices. Many women still opted for preventive mastectomies driven by anxiety and a desire for symmetry rather than the medical data itself. This finding highlights that clinical decision making is deeply emotional and cannot be swayed by numbers alone. It suggests that future counseling tools must address psychological factors and personal fears just as much as they address statistical probabilities to truly support patients in making informed choices. Read the original article at: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843738 Follow us on Ins...
Read more